FDA Inspection
Bernard H. Doft, M.D.Bernard H. Doft, M.D. – FDA Inspection, Sep 28, 2012
Record Details
This FDA Inspection record concerns Bernard H. Doft, M.D., with an inspection on September 28, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bernard H. Doft, M.D.
- Inspection Date
- September 28, 2012
- Product Type
- Drugs
View Company Profile
ID · a1e481c2-3db9-44bf-90e2-73322837f61f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 802634
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 50.27(b)(2)Short form: Oral presentation/signing
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bernard H. Doft, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bernard H. Doft, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.